162 related articles for article (PubMed ID: 15470269)
21. Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy.
Poirier MC; Gibbons AT; Rugeles MT; Andre-Schmutz I; Blanche S
Curr Opin Pediatr; 2015 Apr; 27(2):233-9. PubMed ID: 25635584
[TBL] [Abstract][Full Text] [Related]
22. Decrease of mitochondrial DNA level in sperm from patients infected with human immunodeficiency virus-1 linked to nucleoside analogue reverse transcriptase inhibitors.
Pavili L; Daudin M; Moinard N; Walschaerts M; Cuzin L; Massip P; Pasquier C; Bujan L
Fertil Steril; 2010 Nov; 94(6):2151-6. PubMed ID: 20153854
[TBL] [Abstract][Full Text] [Related]
23. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.
Liu K; Sun Y; Liu D; Yin J; Qiao L; Shi Y; Dong Y; Li N; Zhang F; Chen D
PLoS One; 2013; 8(2):e57223. PubMed ID: 23468942
[TBL] [Abstract][Full Text] [Related]
26. [Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques].
Sergerie M; Martinet S; Kiffer N; Teulé R; Pasquier C; Bujan L
Gynecol Obstet Fertil; 2004 Oct; 32(10):841-9. PubMed ID: 15501159
[TBL] [Abstract][Full Text] [Related]
27. Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.
Moyle G
Clin Ther; 2000 Aug; 22(8):911-36; discussion 898. PubMed ID: 10972629
[TBL] [Abstract][Full Text] [Related]
28. Update on mitochondrial toxicity: where are we now?
Walker UA
J HIV Ther; 2003 May; 8(2):32-5. PubMed ID: 12838162
[TBL] [Abstract][Full Text] [Related]
29. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
Negredo E; Miró O; Rodríguez-Santiago B; Garrabou G; Estany C; Masabeu A; Force L; Barrufet P; Cucurull J; Domingo P; Alonso-Villaverde C; Bonjoch A; Morén C; Pérez-Alvarez N; Clotet B;
Clin Infect Dis; 2009 Sep; 49(6):892-900. PubMed ID: 19663689
[TBL] [Abstract][Full Text] [Related]
30. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
31. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
[TBL] [Abstract][Full Text] [Related]
32. Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.
Saitoh A; Fenton T; Alvero C; Fletcher CV; Spector SA
Antimicrob Agents Chemother; 2007 Dec; 51(12):4236-42. PubMed ID: 17893156
[TBL] [Abstract][Full Text] [Related]
33. Uridine in the prevention and treatment of NRTI-related mitochondrial toxicity.
Walker UA; Venhoff N
Antivir Ther; 2005; 10 Suppl 2():M117-23. PubMed ID: 16152713
[TBL] [Abstract][Full Text] [Related]
34. Coenzyme Q10 Alleviates Chronic Nucleoside Reverse Transcriptase Inhibitor-Induced Premature Endothelial Senescence.
Chen YF; Hebert VY; Stadler K; Xue SY; Slaybaugh K; Luttrell-Williams E; Glover MC; Krzywanski DM; Dugas TR
Cardiovasc Toxicol; 2019 Dec; 19(6):500-509. PubMed ID: 31020509
[TBL] [Abstract][Full Text] [Related]
35. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
[TBL] [Abstract][Full Text] [Related]
36. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
37. The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.
Nolan D; Mallal S
J HIV Ther; 2004 May; 9(2):34-40. PubMed ID: 15238874
[TBL] [Abstract][Full Text] [Related]
38. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial DNA impairment in nucleoside reverse transcriptase inhibitor-associated cardiomyopathy.
Kohler JJ; Hosseini SH; Lewis W
Chem Res Toxicol; 2008 May; 21(5):990-6. PubMed ID: 18393452
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial toxicity and HIV therapy.
White AJ
Sex Transm Infect; 2001 Jun; 77(3):158-73. PubMed ID: 11402222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
